Biomarkers in Alzheimer's and Parkinson's Disease Research and Drug Discovery

Biomarkers in Alzheimer’s & Parkinson’s Disease Research

Comprehensive Biomarker Testing for Global Neurodegenerative Disease Trials  At MLM Medical Labs, we bring 30 years of expertise in delivering comprehensive central and specialty lab support for complex global clinical trials, including Alzheimer’s and Parkinson’s Disease research. Cutting-Edge Biomarker Solutions for Neurodegeneration We offer a robust portfolio of neurodegeneration biomarkers, ensuring high-quality, reliable data to […]

Biomarkers in Alzheimer’s & Parkinson’s Disease Research Read More »

Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH More Fitting Term

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term

by Katie Dineen, B.S. Biology, Business Development Manager, Preclinical Research Lab Introduction:  Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and liver cell damage. One crucial aspect contributing to the development and progression of NASH is metabolic dysfunction.   Understanding NASH:  NASH falls under the broader category of nonalcoholic fatty liver disease (NAFLD),

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term Read More »

PBMC Isolation and Processing in Preclinical and Clinical Trial Research at MLM Medical Labs

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services

In the rapidly evolving landscape of biopharma, the need for precise, reliable, and scalable cellular resources has never been more critical. At MLM Medical Labs, we specialize in providing high-quality Peripheral Blood Mononuclear Cells (PBMCs) to support cutting-edge research and development across a variety of therapeutic areas. Why Partner with MLM?Our PBMC lab services are

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services Read More »

Leverage MLM’s Comprehensive Immunoassay Capabilities to Accelerate Your Preclinical and Clinical Trial Program

:everage MLM’s Comprehensive Immunoassay Capabilities to Accelerate Your Preclinical and Clinical Trial Program At MLM, we specialize in providing cutting-edge, fully customizable immunoassay solutions tailored to meet the complex requirements of your preclinical and clinical trial. Our state-of-the-art laboratories in Germany and the U.S. are equipped with a broad range of immunoassay technologies, allowing us

Leverage MLM’s Comprehensive Immunoassay Capabilities to Accelerate Your Preclinical and Clinical Trial Program Read More »

Bleomycin-induced IPF models at MLM Medical Labs are an invaluable tool in preclinical research on IPF.

Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery

by Katie Dineen, B.S., Business Development Manager – Preclinical Research Lab 🎭 Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery 🌌  Imagine a play where the script is written in invisible ink, characters wear disguises, and the plot takes unexpected twists – that’s Idiopathic Pulmonary Fibrosis (IPF). 🎭 This lung-drama unfolds with a mysterious

Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery Read More »

Histology and Digital Pathology Lab at MLM Medical Labs

Advancing Biopharma Research with Precision Histology and Digital Pathology Services

At MLM, our Histology and Digital Pathology lab and experienced team of PhD-led scientists are equipped to support biopharma companies at the forefront of research into new drugs and therapies, offering specialized services tailored to meet your exacting needs. Our state-of-the-art facilities which feature the Aperio GT 450 DX automated digital pathology scanner from Leica

Advancing Biopharma Research with Precision Histology and Digital Pathology Services Read More »

Scleroderma Awareness Month

Innovating for a Brighter Future in Scleroderma Research

June marks Scleroderma Awareness Month, a crucial period dedicated to raising awareness about this challenging autoimmune disease and highlighting its profound impact on countless lives. At MLM Medical Labs, we are steadfastly committed to advancing research and supporting therapeutic initiatives to combat systemic sclerosis (SSc), a severe manifestation of scleroderma.

Innovating for a Brighter Future in Scleroderma Research Read More »

Digital pathology in drug discovery

Unlocking the Future of Research: Exploring the Advancements and Trajectory of Digital Pathology in Scientific Inquiry

Digital Pathology represents a revolutionary convergence of tissue research and technology, catalyzing transformative changes in the field of pathology research. This innovative approach to pathology holds immense potential, offering a myriad of benefits and paving the way for exciting future possibilities in healthcare research.

Unlocking the Future of Research: Exploring the Advancements and Trajectory of Digital Pathology in Scientific Inquiry Read More »

Obesity and Obesity-related disease research

Exploring the Potential of Ozempic® and Similar Drugs in Treating Obesity-Related Diseases

Here at MLM Medical Labs, we’re at the forefront of this groundbreaking research endeavor. Our dedicated team is committed to unraveling the intricate mechanisms underlying obesity-related diseases and evaluating the therapeutic efficacy of Ozempic type drugs through our advanced preclinical models and comprehensive ex-vivo assessments.

Exploring the Potential of Ozempic® and Similar Drugs in Treating Obesity-Related Diseases Read More »